U.S. Insurance Stock News

If you are asking whether Ashland shares offer fair value at around US$53.18, it helps to first line up the recent share price moves with what the fundamentals might justify. The stock has recently shown a sharp mix of returns, with a 9.0% gain over the last 7 days sitting alongside a 14.7% decline over 30 days, an 11.1% decline year to date, and a 7.1% decline over 1 year, as well as weaker 3 and 5 year returns of 44.6% and 35.4% declines respectively. These moves have brought Ashland back...

In March 2026, Trinity Capital Inc. declared monthly regular dividends of US$0.17 per share for April, May, and June 2026, and also committed US$50,000,000 in growth capital to Sage Health, while forming a new joint venture with Capital Southwest Corporation to invest in first-out senior secured debt. Together, the healthcare financing commitment, the equal US$50,000,000 joint venture with Capital Southwest, and the continued monthly dividends highlight Trinity Capital’s focus on income...

Rocket Lab Corporation recently completed its first dedicated launch for the European Space Agency, carrying the Celeste navigation demonstration satellites to low Earth orbit on its Electron rocket from New Zealand. This mission adds ESA to Rocket Lab’s roster of national space program customers, reinforcing its role as a commercial launch provider for government navigation and technology demonstration projects. We’ll now examine how securing ESA as a launch customer could influence Rocket...

If you are wondering whether Hamilton Insurance Group's current share price still offers value after a strong run, the recent numbers give you plenty to think about. The stock closed at US$28.61, with a 0.2% move over the last 7 days, a 9.4% decline over 30 days, a 4.9% gain year to date, and a 43.5% return over the last year. These mixed short term moves against a strong 1 year return have put the focus squarely on what investors are now willing to pay for Hamilton Insurance Group and why...

Ionis Pharmaceuticals recently announced that the FDA has accepted for Priority Review its New Drug Application for zilganersen, an investigational RNA-targeted therapy for the rare and often fatal neurological disorder Alexander disease, based on a pivotal study showing clinically meaningful stabilization in gait speed and supportive safety data. This milestone underscores Ionis’s ability to advance antisense oligonucleotide medicines into late-stage regulatory review for ultra-rare...

What Recent Performance Says About Range Resources Range Resources (RRC) has drawn fresh attention after a strong recent run, with the stock showing positive moves over the past week, month and past 3 months that stand out against its longer term record. See our latest analysis for Range Resources. The recent 1-day share price return of 1.75% and 30-day share price return of 15.43% sit alongside a 1-year total shareholder return of 22.76% and 5-year total shareholder return of about 3.5x...

Recent commentary on Cullen/Frost Bankers (CFR) has focused on its slowing revenue growth compared with the five-year trend, projected declines in tangible book value, and softer capital generation, all contributing to a more cautious profitability outlook. See our latest analysis for Cullen/Frost Bankers. The recent concerns around slower revenue growth and a softer outlook on tangible book value sit against a mixed price picture. Cullen/Frost Bankers is trading at US$133.70 after a 3.8% 90...

Why OGE Energy (OGE) is on investors’ radar today Recent trading in OGE Energy (OGE) has brought the stock back into focus, with short term returns mixed across the past week and month while longer periods show different patterns for shareholders. See our latest analysis for OGE Energy. At a share price of US$47.54, OGE Energy has recently seen a mix of short term moves and stronger medium term momentum, with a 90 day share price return of 10.82% alongside a 1 year total shareholder return of...

Microchip Technology (NasdaqGS:MCHP) introduced its new automotive grade SAM9X75D5M System in Package hybrid MCU, targeting next generation automotive and industrial designs. The device combines processor and DDR memory in a single package to support embedded displays, connectivity and real time operating systems as well as Linux based systems. The launch is aimed at applications such as digital cockpits, EV charging systems and smart instrument clusters, where display performance and supply...

Why SLM’s latest quarter is drawing fresh attention SLM (SLM) has come back into focus after reporting revenue growth of 16.4% year on year and topping analyst EPS and revenue estimates, a combination that often prompts investors to reassess the stock. See our latest analysis for SLM. The strong quarter has come against a mixed share price backdrop, with a recent 8.64% 1 month share price return offset by a 25.72% year to date share price decline and a 28.18% 1 year total shareholder return...

If you are wondering whether AtaiBeckley's recent share price really reflects its underlying worth, you are not alone. The stock last closed at US$3.35, with returns of a 4.0% decline over 7 days, 7.7% decline over 30 days, 13.4% decline year to date and 127.9% over the past year. This naturally raises questions about how the current price lines up with fundamentals and risk. Recent coverage has focused on AtaiBeckley's position in the Pharmaceuticals and Biotech space and how sentiment...

Consumers Energy, a CMS Energy subsidiary, recently received regulatory approval for its 2026 Reliability Action Plan, authorizing significant upgrades to Michigan’s electric grid to improve service for nearly 2 million homes and businesses affected by severe weather. This approval reinforces regulatory backing for continued grid investment, potentially strengthening CMS Energy’s position as Michigan’s key provider of long-term electric reliability and infrastructure resilience. We’ll now...

Recent share performance and business snapshot Wynn Resorts (WYNN) shares closed at US$96.59, with the stock showing a 2.9% decline over the past day and a 3.4% decline over the past week, prompting fresh attention from investors. Over the past month the stock has recorded a 10.7% decline and over the past 3 months a 21.0% decline, alongside a value score of 2 that may lead some investors to reassess how they view the company. Wynn Resorts generates US$7.14b in revenue and US$327.33m in net...

AMD (NasdaqGS:AMD) CEO Lisa Su hosted U.S. Commerce Secretary Gina Raimondo for high-level talks on semiconductor leadership and domestic manufacturing. The meeting focused on AMD's role in the U.S. technology supply chain and ongoing national semiconductor initiatives. For investors watching AMD (NasdaqGS:AMD), this kind of direct engagement with the Commerce Department highlights how central chip design and manufacturing capacity have become to U.S. industrial priorities. AMD designs...

In March 2026, Zymeworks Inc. reported that an oral presentation of new Phase 1 clinical data for its folate receptor alpha-targeting antibody-drug conjugate ZW191, along with six additional abstracts from its wholly owned oncology R&D portfolio, had been accepted for the American Association for Cancer Research Annual Meeting in San Diego. The breadth of clinical and preclinical data, spanning ZW191 and multiple pan-RAS inhibitor antibody-drug conjugate candidates across RAS-mutated and...

Tecnoglass Inc. previously declared a quarterly dividend of US$0.15 per share for the first quarter of 2026, payable on April 30 to shareholders of record on March 31, while 10% owner Energy Holding Corp recently acquired 306,666 shares in open-market purchases. This combination of continued cash returns via dividends and fresh insider buying highlights confidence in Tecnoglass’s capital allocation and business outlook despite earlier earnings underperformance. With insider buying...

If you are wondering whether Expeditors International of Washington is fairly priced or if the market is overlooking something, this article focuses squarely on what you are getting for the current share price. The stock last closed at US$141.22, with returns of 19.4% over 1 year, 32.9% over 3 years and 37.5% over 5 years. Year to date, the share price shows a 7.0% decline, including a 3.5% decline over the past week and 2.6% over the past month. Recent news coverage has largely centered on...

If you are wondering whether Mondelez International at around US$58.27 is a bargain or just fairly priced, you are not alone. The stock has had a mixed run, with a 3.7% gain over the past week, a 5.4% decline over the last 30 days, an 8.6% return year to date, and a 11.2% loss over the past year. Recent headlines have focused on Mondelez International as a global snacks player, with investors weighing brand strength, cost pressures, and consumer demand trends. That context has been important...

Why Olema’s latest earnings and shelf filing matter for investors Olema Pharmaceuticals (OLMA) has drawn fresh attention after reporting fourth quarter and full year 2025 results, along with a new shelf registration of up to US$71.82 million in common stock. The company posted a fourth quarter net loss of US$46.06 million and a full year 2025 net loss of US$162.45 million. It also registered 4,882,586 shares for an ESOP related offering that could affect future dilution and funding...

Key recent performance and what it might mean for investors Revolution Medicines (RVMD) shares have seen mixed recent returns, with a 1 day decline of 0.75%, a 3.4% drop over the past week, and a roughly 9.3% decline over the past month. Over the past 3 months, however, the stock shows a gain of about 14.9%, and year to date it is up roughly 17.1%. This provides investors with a sense of how sentiment has shifted across different time frames. See our latest analysis for Revolution...

In March 2026, Aurinia Pharmaceuticals underwent a sweeping leadership overhaul, with Board Chair Kevin Tang becoming CEO and principal executive officer, joined by new CFO Michael Hearne, COO Ryan Cole, and Chief Scientific Officer Thomas Wei as several prior C-suite leaders departed. This reshuffle consolidates operational control around Tang Capital–linked executives, signaling a potential shift in how Aurinia balances capital allocation, operations, and pipeline priorities. Next, we’ll...

If you are wondering whether Waters at around US$289.16 is starting to look interesting on valuation, this breakdown will help you put the current share price in context. The stock has seen a 3.3% decline over the last 7 days and is down 9.5% over 30 days, with year to date returns of a 24.3% decline and a 20.2% decline over the past year, adding to the sense that expectations and perceived risk have shifted. Recent commentary around Waters has focused on its position within the Life...

In March 2026, RXO expanded its RXO Extra marketplace, adding a premium load-booking experience with white-glove onboarding, concierge support, bonus payments, and deeper discounts for carriers using its fuel card and factoring services. This enhancement strengthens RXO’s carrier value proposition by tying better digital load access and rewards directly to adoption of its financial and fuel programs. We’ll now examine how the new premium load-booking and rewards structure may influence RXO’s...

In March 2026, Critical Metals Corp. filed a US$25.16 million shelf registration for 2,744,062 ordinary shares and appointed veteran international trade attorney and commodities investor Chang Oh Turkmani to its Advisory Board. Her long track record in cross-border commodity deals, infrastructure logistics, and energy projects may influence how investors view Critical Metals’ global growth ambitions and risk management around complex international transactions. Next, we’ll examine how...